반응형 gemvax #gv1001 #alzheimerstreatment #biotechstocks #dementiadrug #gemvaxclinicaltrial #drugdevelopment #peptidetherapy #pharmanews #gemvaxoutlook1 GemVax GV1001: A New Hope for Alzheimer’s Treatment 🧠 1. GV1001: GemVax's Core Drug CandidateGV1001 is a peptide-based new drug candidate developed by GemVax & KAEL, currently drawing attention as a key pipeline for Alzheimer's treatment. Initially designed as an anticancer drug, it has shown strong neuroprotective and anti-inflammatory properties, making it promising for neurodegenerative diseases. GV1001 works by stabilizing mitochondrial func.. 2025. 4. 6. 이전 1 다음 반응형